NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Frost & Sullivan
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest Amongst All End Users Finds Frost & Sullivan - The US digital therapeutics (DTx) market is estimated to witness more than three-and-a-half-fold growth reaching $4.54 billion by 2025, at a CAGR of 29.8% - Frost.com
Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest Amongst All End Users Finds Frost & Sullivan

 

NewswireToday - /newswire/ - Santa Clara, CA, United States, 2021/08/09 - The US digital therapeutics (DTx) market is estimated to witness more than three-and-a-half-fold growth reaching $4.54 billion by 2025, at a CAGR of 29.8% - Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering IT Services / Network Management Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Frost & Sullivan’s recent analysis finds that digital therapeutics (DTx) in the United States are considered legitimate alternatives to traditional pharmacotherapy. These solutions are comprehensively regulated and granted prescription status by various national or state-level regulatory agencies based on reported evidence of improved clinical outcomes for a defined patient population.

As life sciences companies aim to enhance patients’ treatment experiences and find new biomarkers that aid drug discovery, DTx companies diversify their pipelines by adding new indications, addressing unmet needs. Consequently, this market is estimated to witness more than three-and-a-half-fold growth, reaching $4.54 billion by 2025 from $1.23 billion in 2020, expanding exponentially at a compound annual growth rate (CAGR) of 29.8%.

“In the next three to five years, multiple technology vendors will offer digital treatments that will be regarded as safe and effective as subscriptions to personalized medication,” said Koustav Chatterjee, Healthcare & Life Sciences Principal at Frost & Sullivan. “Additionally, patients would be allowed or advised to modify dosages and reduce consumption of non-emergency medications based on their daily vitals that DTx solutions will capture and contextualize.”

Chatterjee added: “Patient-centric digital health vendors have strived for a business model that allows physicians to recommend their products, patients to use them for a defined period (without fail), caregivers to monitor outcomes 24/7, and payers to reimburse the cost of usage. Further, DTx companies partnering with payers, providers and life sciences companies provide the best way of getting access to patients for scalability, apart from risk-sharing agreements.”

Over the next two to three years, biopharma companies also will highly invest in DTx solutions, enabling the subsidized cost to patients in exchange for marketing and access to patient data. As a result, Frost & Sullivan identified the following growth opportunities for market participants:

• Prescription-grade software-as-a-medical-device (SaMD) that auto-upgrades treatment plans based on patient’s biomarker reading for dosage optimization: SaMD should be able to capture, consolidate, and normalize patient data and recommend personalized actions for medication and care plan adjustments.

• DTx-related platform-as-a-service (PaaS) capability that specializes in multiple therapeutic areas to help IT companies build capabilities at scale: The PaaS capability has to be modular and multi-therapeutic as the target audience for these solutions often carries multiple chronic comorbidities.

• DTx to support evidence-based treatment and medication adherence for patients, providers, and payers: Biopharma should work with the DTx companies to develop use cases and value propositions that inform patients about the range of benefits offered and impact on outcomes.

US Digital Therapeutics Growth Opportunities is the latest addition to Frost & Sullivan’s Healthcare & Life Sciences research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Frost & Sullivan

For six decades, Frost & Sullivan (frost.com) has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

US Digital Therapeutics Growth Opportunities / K5CF

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering IT Services / Network Management Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
IT Services / Network Management articles,
CATCH Visitors via Your Competitors Announcements!


Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest Amongst All End Users Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Mariana Fernandez - Frost.com 
877-463-7678 mariana.fernandez[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

IT Services / Network Management via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read IT Services / Network Management Most Recent Related Newswires:

Yokogawa and NTT Communications Enter into Business Partnership Agreement for the Joint Development and Provision of a Shared-Use OT Cloud Service
Yokogawa Invests in Web Synergies to Expand Global Digital Transformation Capabilities
NEC Wins 2021 Leading Lights Award for ‘Best New 5G Core Product’ and ‘Best New Open RAN Product’
Cisco Lauded by Frost & Sullivan for Supporting Industrial IoT Deployments with its Leading Portfolio of Secure and Scalable Solutions
Keysight Commended by Frost & Sullivan for Dominating the Network Packet Brokers Market with a Compelling Portfolio of Solutions
Arista Expands its Cognitive Campus with the Latest Generation Wi-Fi 6E Solution
RightITnow Introduces A Deploy Anywhere Monitor Everything with ECM Model
NEC Corporation, OCC Corporation and Sumitomo Electric Industries, Ltd Complete First Trial of Submarine Cable with Multicore Fiber
ScienceLogic Deepens Network Readiness and Resilience with Restorepoint Acquisition
Infostretch Achieves AWS Life Sciences Competency
Rising Data Creation and Consumption Fuel the Data Center Colocation Services Market Worldwide Says Frost & Sullivan
GÉANT Delivers 800G Transmission on Research & Education Network with Infinera ICE6
Arista Selected to Build Australian Securities Exchange Next Generation Campus Network
South Reach Networks Offers New Services Powered by Infinera’s Industry-leading Open Optical Solutions
Arista Extends Cloud-Grade Routing to the Network Edge

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  The Franchise Group





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)